Audion Therapeutics touted positive results yesterday from a Phase I trial of the company’s hearing loss drug. In 15 people with mild to moderate sensorineural hearing loss, Audion tested the safety and tolerability of its LY3056480 mediated Notch inhibitor. The drug is designed to regenerate the inner ear sensory hair cells that are lost over time. […]
These headphones can clean your ears
Tucson-based startup SafKan has developed a pair of headphones that can professionally clean a patient’s ear in just 35 seconds. Winner of Protolabs’ Cool Idea! Award, SafKan is working on meeting customization requirements during the pivotal beta program stage for its device, OtoSet. The headphones have disposable silicone nozzles that spray a warm saline solution against the walls of the ear canal […]
Decibel, Cocoon tackle drug delivery to the inner ear using silk
Decibel Therapeutics and Cocoon Biotech announced yesterday that the two companies plan to work together to research drug formulations optimized for transtympanic delivery to the ear. The collaboration will make use of Cocoon’s silk fibroin platform and Decibel will have an option to exclusively license the technology on a program-by-program basis. Get the full story at our sister […]
Tivic Health’s OTC sinus pain device wins FDA nod
Tivic Health Systems said that its ClearUP device for allergy-induced sinus pain has received 510(k) clearance from FDA. ClearUP is an over-the-counter device that provides consumers with a simple, non-invasive and drug-free option to relieve sinus pain caused by various environmental allergies such as dust, mold, pollens and pet dander, according to the […]
Frequency Therapeutics raises $42m for hearing regeneration drug
Frequency Therapeutics said today that it closed a $42 million Series B round to support the clinical development of its hearing regeneration drug, FX-322. The company is slated to publish top-line data from an ongoing Phase I/II study of FX-322 in the first half of the year. Get the full story at our sister site, Drug […]
Intersect ENT launches trial of drug-coated sinus balloon
Intersect ENT (NSDQ:XENT) said today that it enrolled the first patient in a trial of its Ascend drug-coated sinus balloon. The Menlo Park, Calif.-based company’s device is designed to deliver mometasone furoate directly to a person’s sinuses at the time of dilation. Get the full story at our sister site, Drug Delivery Business News.
Sonova licenses Ceva’s RivieraWaves Bluetooth tech for Sword 3.0 hearing aid chip
Sonova Holding AG (SIX:SOON) has inked a deal to license Ceva’s RivieraWaves Bluetooth intellectual property for use in its Sword 3.0 wireless hearing aid chip, Ceva said today. The licensed RivieraWaves Bluetooth IP platform consists of a hardware baseband controller and software protocol stack and will help power the Sword 3.0, which Sonova touts as the […]
E-Motion Medical wins CE Mark for acute digestive dysmotility stimulator
E-Motion Medical said yesterday that it won CE Mark approval in the European Union for its E-Motion stimulation therapy system intended to treat patients with acute gastrointestinal dysmotility. The Israel-based company said that the E-Motion system is designed to deliver “unique patterns” of electrical stimulation to the esophagus using its E-Motion tube, which is placed […]
Intersect ENT touts pooled analysis of steroid-releasing sinus implants
Intersect ENT (NSDQ:XENT) last week touted the publication of a pooled analysis of the company’s Propel Contour and Propel Mini steroid-eluting sinus implants. The company’s devices are designed to prop open the sinus ostia following endoscopic sinus surgery. As the implant dissolves, medicine is delivered directly to the sinus lining. Get the full story at our […]
Intersect ENT tops estimates with Q3 results
Shares in Intersect ENT (NSDQ:XENT) fell today even though the medical device maker topped expectations on Wall Street with its third-quarter financial results. The Menlo Park, Calif.-based company posted a net loss of -$7.6 million on sales of $24.7 million for the 3 months ended Sept. 30, for sales growth of 11% compared with the same period last […]
Earlens closes $87m offering
Earlens said today it closed an $87 million round of financing to help support continued development and a next-gen rollout of its hearing aid technology. The round was led by newly invested KCK Ltd., and joined by Exor Seets and previously invested Lightstone Ventures, CRG Partners, Windham Life Sciences Partners, Arch Healthcare, Relativity Health Fund, […]
- 1
- 2
- 3
- …
- 13
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube